Santikos Suite offers capability to study Alzheimer’s, other diseases
Thursday, October 5, 2017
William L. Henrich, M.D., MACP, president of UT Health San Antonio, recognized the John L. Santikos Charitable Foundation, a fund of the San Antonio Area Foundation, on Oct. 2 for its $2.3 million gift to build the John L. Santikos CT and Nuclear Medicine Suite at the university. view more
Express-News: Childhood cancer needs more attention
Monday, October 2, 2017
The following appeared in the San Antonio Express-News on Sept. 24. The author is Gregory J. Aune, M.D., Ph.D., assistant professor of pediatrics at the Greehey Children’s Cancer Research Institute.
September is Childhood Cancer Awareness Month. Many citizens in our community may not realize that San Antonio is home to the Greehey Children’s Cancer Research Institute — the largest freestanding pediatric cancer research facility in Texas and one of the few research institutes worldwide devoted exclusively to childhood cancer. view more
Greehey Institute contributes to survey of RAS-sensing antibodies
Thursday, September 28, 2017
Researchers from the Greehey Children’s Cancer Research Institute at UT Health San Antonio are co-authors on a paper published Sept. 26 in Science Signaling, a high-impact journal that is part of the Science family of journals. view more
New cancer center director welcomed
Thursday, September 14, 2017
A reception honoring new UT Health Cancer Center Director Ruben A. Mesa, M.D., was held Sept. 14. Dr. Mesa began his post in August.
The event was hosted by President William L. Henrich, M.D., MACP; Ron Rodriguez, M.D., Ph.D., interim dean of the Joe R. & Teresa Lozano Long School of Medicine; and Department of Medicine Chair W. Brian Reeves, M.D. view more
UT Health team finds way to measure key cell regulator’s activity
Tuesday, September 5, 2017
UT Health San Antonio researchers and co-authors in New York state on Monday (Sept. 4) reported an innovative approach that will enable scientists to study the most common regulator of our bodies’ cells, a molecule called guanosine-5′-triphosphate (GTP).
Nature Methods, the world’s most prestigious journal for reporting novel biomedical technologies, published the team’s findings. view more
CPRIT awards millions to UT Health San Antonio
Friday, August 18, 2017
Cancer prevention programs and initiatives to recruit faculty to UT Health San Antonio got a $3.5 million boost from the Cancer Prevention & Research Institute of Texas (CPRIT).
The awards, announced Aug. 16, bring total funding to UT Health San Antonio by CPRIT to about $74.6 million since the program began in 2008. The UT Health Cancer Center is one of the state’s National Cancer Institute-designated Cancer Centers, and is a leader in cancer control programs. view more
H-E-B joins UT institutions to raise money for cancer patients
Tuesday, August 15, 2017
H-E-B is launching a fundraising campaign with The University of Texas MD Anderson Cancer Center to help create a future free from cancer. Beginning Aug. 16 and running through Sept. 12, H-E-B customers will have the opportunity to make $1, $3 and $5 donations at the register. A portion of campaign funds raised in San Antonio will be donated to UT Health San Antonio MD Anderson Cancer Center, a new clinical partner serving San Antonio and South Texas, and MD Anderson in Houston. During last year’s campaign, H-E-B raised more than $400,000 for MD Anderson. view more
Express-News: Weight loss, exercise important for breast cancer patients under 60
Tuesday, August 15, 2017
It was spring 2015 when Janie Barrera first noticed the small lump in her breast.
Read the full story at the Express-News
The post Express-News: Weight loss, exercise important for breast cancer patients under 60 appeared first on UT Health Science Center News.
New agent blocks growth of recurring breast cancer tumors
Wednesday, August 9, 2017
Researchers at UT Health San Antonio and two partner institutions are developing a new, first-in-class agent that has stopped the growth of estrogen receptor-positive breast cancer in its tracks. The new agent is a molecule called ERX-11 that has blocked the growth of recurring breast cancer tumors. view more
Researcher contributes to screening guidelines for pediatric cancers
Wednesday, August 2, 2017
Approximately 10 percent of childhood cancer can be attributed to genetics. While genomic analysis has been used for some time to identify the risk of inherited cancer in adults, scientists are now using genomic analysis to identify genetic risk factors and to diagnose cancer at an early age in children.
Gail Tomlinson, M.D., Ph.D. view more